Evidence map›Paper›PMID 23990461›Full record

ArticleThe Journal of biological chemistry2013

Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.

Angela M Gajda, Yin Xiu Zhou, Luis B Agellon, Susan K Fried, Sarala Kodukula, Walter Fortson, Khamoshi Patel, Judith Storch

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Echo2Pheno: a deep-learning application to uncover echocardiographic phenotypes in conscious mice.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Angela M GajdaFrom the Department of Nutritional Sciences and; the Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey 08901.
Yin Xiu ZhouFrom the Department of Nutritional Sciences and.
Luis B Agellonthe School of Dietetics and Human Nutrition, McGill University, Montréal, Québec H9X 3V9, Canada, and.
Susan K Friedthe Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
Sarala KodukulaFrom the Department of Nutritional Sciences and.
Walter FortsonFrom the Department of Nutritional Sciences and.
Khamoshi PatelFrom the Department of Nutritional Sciences and.
Judith StorchFrom the Department of Nutritional Sciences and; the Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey 08901,. Electronic address: Storch@aesop.rutgers.edu.
Nutrition Sciences (Belgium) · BEBoston University · USMcGill University · CARutgers, The State University of New Jersey · US

Funding

Supplement to DK-38389 Lipid Transport in the IntestineR01DK038389 · NIDDK · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI SAMPATH, HARINI, STORCH, JUDITH · 1992 to 2025
$8.6M
FATTY ACID ASSIMILATION IN THE INTESTINER29DK038389 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STORCH, JUDITH · 1987 to 1991
–
NIDDK NIH HHS DK-38389NIDDK NIH HHS R01 DK038389
6 · The paper itself

Abstract

The enterocyte expresses two fatty acid-binding proteins (FABP), intestinal FABP (IFABP; FABP2) and liver FABP (LFABP; FABP1). LFABP is also expressed in liver. Despite ligand transport and binding differences, it has remained uncertain whether these intestinally coexpressed proteins, which both bind long chain fatty acids (FA), are functionally distinct. Here, we directly compared IFABP(-/-) and LFABP(-/-) mice fed high fat diets containing long chain saturated or unsaturated fatty acids, reasoning that providing an abundance of dietary lipid would reveal unique functional properties. The results showed that mucosal lipid metabolism was indeed differentially modified, with significant decreases in FA incorporation into triacylglycerol (TG) relative to phospholipid (PL) in IFABP(-/-) mice, whereas LFABP(-/-) mice had reduced monoacylglycerol incorporation in TG relative to PL, as well as reduced FA oxidation. Interestingly, striking differences were found in whole body energy homeostasis; LFABP(-/-) mice fed high fat diets became obese relative to WT, whereas IFABP(-/-) mice displayed an opposite, lean phenotype. Fuel utilization followed adiposity, with LFABP(-/-) mice preferentially utilizing lipids, and IFABP(-/-) mice preferentially metabolizing carbohydrate for energy production. Changes in body weight and fat may arise, in part, from altered food intake; mucosal levels of the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamine were elevated in LFABP(-/-), perhaps contributing to increased energy intake. This direct comparison provides evidence that LFABP and IFABP have distinct roles in intestinal lipid metabolism; differential intracellular functions in intestine and in liver, for LFABP(-/-) mice, result in divergent downstream effects at the systemic level.

Indexed as

AnimalsDietary FatsFatty Acid-Binding ProteinsFatty AcidsMiceMice, KnockoutOxidation-ReductionPhospholipidsTriglyceridesDietary FatsFabp1 protein, mouseFabp2 protein, mouseFatty Acid-Binding ProteinsFatty AcidsPhospholipidsTriglyceridesFatty AcidFatty Acid-binding ProteinIntestineLipid MetabolismMonoacylglycerol

Identifiers

PMID23990461
PMCPMC3798498
OpenAlexW2051403503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.